The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

Item
http://www.wikidata.org/entity/Q33658554
Targeting folate receptor alpha for cancer treatmentEstablishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma.Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed.Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the futureTherapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter.Systemic treatment of malignant pleural mesothelioma.Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy.Farletuzumab, an anti-folate receptor α antibody, does not block binding of folate or anti-folates to receptor nor does it alter the potency of anti-folates in vitro.Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools.Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations.Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma
P2860

The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.

Item
http://www.wikidata.org/entity/Q33658554
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The role of folate receptor al ...... rexed-containing chemotherapy.
@ast
The role of folate receptor al ...... rexed-containing chemotherapy.
@en
type
label
The role of folate receptor al ...... rexed-containing chemotherapy.
@ast
The role of folate receptor al ...... rexed-containing chemotherapy.
@en
prefLabel
The role of folate receptor al ...... rexed-containing chemotherapy.
@ast
The role of folate receptor al ...... rexed-containing chemotherapy.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
The role of folate receptor al ...... rexed-containing chemotherapy.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932